LI Fen
Impact in
-
- Gout, Hyperuricemia, Uric Acid
-
- COVID-19 Clinical Research Studies
Papers in
-
- Dialysis and Renal Disease Management 3
- Chronic Kidney Disease and Diabetes 2
- Co-authors
- Min Tan (1 shared paper)Jing Wu (1 shared paper)Min Wang (1 shared paper)Sheng Chen (1 shared paper)Xiaoxuan Zhang (2 shared papers)Xiaohua Pei (2 shared papers)Xun Liu (2 shared papers)Dan Song (2 shared papers)
- Journals
- DNA and Cell Biology (1 paper)Chinese Journal of Integrative Medicine (1 paper)Annals of the Rheumatic Diseases (1 paper)Journal of Medical Virology (1 paper)Combinatorial Chemistry & High Throughput Screening (1 paper)
- Partner nations
- China
In The Last Decade
LI Fen
21 papers receiving 354 citations
Peers
Comparison fields: 5 of 71
- Nephrology 41
- Infectious Diseases 102
- Obstetrics and Gynecology 24
- Immunology 64
- Neurology 41
Countries citing papers authored by LI Fen
This map shows the geographic impact of LI Fen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LI Fen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LI Fen more than expected).
Fields of papers citing papers by LI Fen
This network shows the impact of papers produced by LI Fen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LI Fen. The network helps show where LI Fen may publish in the future.
Co-authors
The 25 scholars most cited alongside LI Fen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 159 | |
| 2 | 2019 | 104 | |
| 3 | 2021 | 32 | |
| 4 | 2018 | 14 | |
| 5 | 2017 | 7 | |
| 6 | 2014 | 6 | |
| 7 | 2021 | 5 | |
| 8 | 2025 | 5 | |
| 9 | 2023 | 4 | |
| 10 | 2007 | 3 | |
| 11 | Experimental research of the immunoregulatory action of polysaccharides of Lily. | 2010 | 3 |
| 12 | 2021 | 3 | |
| 13 | 2016 | 3 | |
| 14 | Roasting oxidation-thiosulfate leaching of gold from refractory gold-bearing sulfur concentrates | 2014 | 2 |
| 15 | 2023 | 2 | |
| 16 | Diagnostic and Prognostic Value of Salivary MiR-10b for Esophageal Cancer | 2016 | 1 |
| 17 | Analysis on the causes of early neonatal death in Shanghai from 1999 to 2008 | 2010 | 1 |
| 18 | [Evaluation of physiological index on treadmill exercise testing of 294 healthy children in Shanghai area]. | 2003 | 1 |
| 19 | 2021 | 1 | |
| 20 | 2022 | 1 |
About LI Fen
LI Fen is a scholar working on Nephrology, Obstetrics and Gynecology, Cancer Research, Rheumatology and Immunology, having authored 21 papers that have together received 358 indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (3 papers), Chronic Kidney Disease and Diabetes (2 papers), Coronary Artery Anomalies (1 paper), COVID-19 Clinical Research Studies (1 paper), Cardiovascular Function and Risk Factors (1 paper), Peroxisome Proliferator-Activated Receptors (1 paper), IL-33, ST2, and ILC Pathways (1 paper) and Pancreatitis Pathology and Treatment (1 paper). The work is most often cited by research in Nephrology (41 citations), Infectious Diseases (102 citations), Obstetrics and Gynecology (24 citations), Immunology (64 citations) and Neurology (41 citations). LI Fen has collaborated with scholars based in China. Frequent co-authors include Min Tan, Jing Wu, Min Wang, Sheng Chen, Xiaoxuan Zhang, Xiaohua Pei, Xun Liu, Dan Song, Yanfen Wang and Weihong Zhao. Their work appears in journals such as DNA and Cell Biology, Chinese Journal of Integrative Medicine, Annals of the Rheumatic Diseases, Journal of Medical Virology and Combinatorial Chemistry & High Throughput Screening.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.